Treatment models from the International Diabetes Center: advancing from oral agents to insulin therapy in type 2 diabetes.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Richard M Bergenstal

Abstract

To discuss treatment models used at the International Diabetes Center (IDC) and present strategies for transitioning patients with type 2 diabetes from orally administered medications to insulin therapy. The experiences of the IDC in developing and improving patient care and educational programs are reviewed. In addition, clinical outcomes and economic results are highlighted. In the management of chronic conditions such as diabetes, the patient is a crucial member of the health-care team. Therefore, patients must understand and endorse treatment goals. Key components of the patient-centered IDC treatment model are group instruction focused on behavioral change, worksite education and coaching programs, and treatment algorithms to help clinicians identify treatment priorities and initiate appropriate therapeutic strategies, including early and more effective use of insulin therapy. The IDC patient-centered team model aimed at helping patients live well with diabetes has been shown to improve achievement of glycemic, lipid, and blood pressure goals, and it is economically viable. One approach to helping more patients with type 2 diabetes reach glycemic targets is for clinicians to become more comfortable with, and therefore more...Continue Reading

References

Nov 14, 1997·The Diabetes Educator·D D Etzwiler
Jun 23, 2001·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·R M Bergenstal
Jan 30, 2002·Diabetes Care·Patti L RickheimDavid M Kendall
Oct 17, 2002·JAMA : the Journal of the American Medical Association·Thomas BodenheimerKevin Grumbach
Apr 4, 2003·JAMA : the Journal of the American Medical Association·Donnell D Etzwiler
Dec 23, 2003·Journal of General Internal Medicine·Michele HeislerTimothy P Hofer

❮ Previous
Next ❯

Citations

Jul 31, 2007·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Eva M Vivian
Sep 28, 2010·Journal of Oncology·Jue WangAnne Kessinger
Jan 1, 2010·International Journal of Surgical Oncology·Jue Wang, Fen Wei Wang
Jan 8, 2015·Journal of Diabetes·Amy T LarkinZachary Bloomgarden
Jul 17, 2009·European Journal of Internal Medicine·David M KendallRichard M Bergenstal
Jun 2, 2009·The American Journal of Medicine·David M KendallRichard M Bergenstal
Jan 29, 2010·Diabetes Care·UNKNOWN American Diabetes Association
Jan 6, 2009·Diabetes Care·UNKNOWN American Diabetes Association
Mar 20, 2010·The Journal of Clinical Endocrinology and Metabolism·Bernard CharbonnelUNKNOWN PROactive investigators
Jan 14, 2011·Diabetes Care·UNKNOWN American Diabetes Association
Jan 10, 2008·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.